November 2007
Worldwide Biotech;Nov2007, Vol. 19 Issue 11, p4
Trade Publication
The article reports on a multi-center, double-blind, placebo-controlled randomized trial to evaluate the efficacy of NeuroAid in reducing neurological deficit and improving independence in patients in rehabilitation, with treatment starting within 48 hours of a stroke. NeuroAid is the first natural compound to be studied in a large clinical trial focused on stroke recovery starting in the acute stage, according to the article.


Related Articles

  • Date set for ACT India course.  // European Pharmaceutical Executive;Jun2007, p11 

    The article provides information on the 2007 Special Edition Short Course of "Applied Clinical Trials" entitled Conducting Clinical Trials in India, which will be held on June 26, 2007 at the Copthorne Tara Hotel in England. It is an intensive one-day seminar that is designed to provide an...

  • They're Dying to Get In. Bjerklie, David // Time International (South Pacific Edition);4/22/2002, Issue 15, p55 

    Discusses the difficulty of being able to participate in clinical trials in medicine. Benefits of the trials, including substantial doctor-patient interaction; Idea that it is not just the terminally ill who benefit from the attention, but also medically neglected or poorly informed subjects...

  • How to Find a Trial. Smith, Ian K. // Time;11/22/1999, Vol. 154 Issue 21, p114 

    Offers information on patient enrollment in clinical drug trials. Researchers' need for patients as well as patients' need for treatment; Reasons adults do not participate in clinical drug trials; Where to locate trials. INSETS: Ace-ing It, by Janice M. Horowitz;Inside Information, by Janice...

  • The Changing Landscape.  // Applied Clinical Trials;Feb2004, Vol. 13 Issue 2, p12 

    Presents an overview of the articles published in the February 2004 issue of the periodical "Applied Clinical Trials." Highlights of the ACT 2004 summit which will be held in Munich, Germany on May 2004; Discussion of the suitability, efficiency and effectiveness of the Italian clinical trial...

  • Phase IIIb Extensive Clinical Studies.  // Applied Clinical Trials;Feb2004, Vol. 13 Issue 2, p44 

    Discusses the activation process of two large Phase IIIb studies, concurrently implemented in a global network of hundreds of Italian centers under the coordination of a single team involving the sponsor. Examination of the overall performance of the Italian clinical trial system regarding the...

  • Delivering Clinical Trial Supplies by Post to Elderly Trial Participants: A Feasibility Study.  // Applied Clinical Trials;Feb2004, Vol. 13 Issue 2, p58 

    Reports on a study conducted by researchers in the U.S., which provides evidence that mailing clinical supplies is a feasible method of dispatching trial medication. Examination of the potential concerns in mailing clinical supplies to elderly trial participants who had recently sustained a...

  • Orphan drugs.  // Applied Clinical Trials;Sep2004, Vol. 13 Issue 9, p16 

    Reports on results of “Applied Clinical trials' online survey of priority issues in the field of clinical trials. Percentage of respondents who voted for recruitment; Increasing cost of drug development; Regulatory bureaucracy; Openness of trial data.

  • GCP's Finality: Personal Integrity. Crawley, Francis P. // Applied Clinical Trials;Mar2006, Vol. 15 Issue 3, p94 

    No abstract available.

  • New Strategies for Research. Lukan, Colette // Applied Clinical Trials;May2008 Supplement, Vol. 17, p6 

    The author reflects on the move of the European Organization for Research and Treatment of Cancer (EORTC) to adopt the European Union Clinical Trials Directive to stimulate science-driven and rapidly evolving discoveries of clinicogenomic research. She states that improvements in cancer...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics